αS-SETMAR: Inducing Protective Chaos in Glioblastoma?

Sarah-Anne David1, Sara Benharrat1, Oriane Lié1

  • 1Université de Tours, INSERM, Imaging Brain & Neuropsychiatry, iBraiN U1253, 37032 Tours, France.

Cancers
|July 15, 2026
PubMed
Abstract

Insights

Overexpressing S-SETMAR in glioblastoma cells slows proliferation and increases chromosomal instability. This dual effect enhances sensitivity to genotoxic stress, suggesting S-SETMAR as a potential therapeutic target for brain cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Glioblastoma is an aggressive brain cancer with poorly understood molecular drivers.
  • SETMAR, a DNA repair protein, is dysregulated in glioblastoma.
  • S-SETMAR, a shorter SETMAR isoform, may counteract oncogenic functions.

Purpose of the Study:

  • To investigate the effects of S-SETMAR overexpression in glioblastoma cells.
  • To explore the molecular and cellular consequences of S-SETMAR in brain cancer.

Main Methods:

  • Compared native glioblastoma cells (8MGBA) with cells overexpressing αS-SETMAR.
  • Utilized complementary cellular and molecular analyses.

Main Results:

  • αS-SETMAR overexpression prolonged cell cycle and decreased proliferation.
  • Induced genomic alterations: increased DNA content, aneuploidy, and chromosomal instability.
  • Enhanced sensitivity to chemotherapy/radiotherapy mimics, increasing apoptosis.

Conclusions:

  • αS-SETMAR dual-modulates glioblastoma: slows proliferation, promotes instability, and increases genotoxic stress vulnerability.
  • Suggests αS-SETMAR as a prognostic marker and potential therapeutic strategy for glioblastoma.

Related Concept Videos